Dr. Jonathan S. Fainberg, MD, MPH

Dr. Fainberg practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Fainberg's NPI, 1780070789, was assigned on April 7, 2015. Dr. Fainberg graduated from Tufts University School Of Medicine in 2015. Dr. Fainberg holds New York license 311006.

Dr. Fainberg's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Fainberg's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Fainberg is also affiliated with Stony Brook University Hospital. The medical group on file is NewYork-Presbyterian Medical Group Queens. Dmand AI also links Dr. Fainberg to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fainberg practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Fainberg's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Fainberg's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists kidney stone disease, kidney stones, urinary endoscopy and UTI among the conditions Dr. Fainberg treats.

CMS data shows 960 Medicare services from Dr. Fainberg across 10 procedure codes in 2024, for 484 Medicare patients. Medicare paid $88,079 for them. Every service was in an office.

CMS counts 484 Medicare patients who saw Dr. Fainberg in 2024. The largest group is 65 to 74, with 271 patients. 75% of them have cancer, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fainberg's median patient age at 72, with 2% women.

In 2024, Dr. Fainberg wrote 263 Medicare Part D claims for 124 patients. 91% of them were for generic drugs. CMS names the drug for 192 of them, across 5 drugs with 11 or more claims each, at $1,969 in total drug cost. In 2023, CMS named 105 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Fainberg for performance year 2024, reported as part of a group. Dr. Fainberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fainberg as offering telehealth.

Dmand AI links 24 papers to Dr. Fainberg, published from 2019 to 2024. 2019 was the busiest year, with 8. The most frequent topics are Prostatic Neoplasms, Magnetic Resonance Imaging and Biopsy. Dr. Fainberg has published most often in J Urol. Dr. Fainberg's most frequent co-authors are Behfar Ehdaie, MD, Gregory Thomas Chesnut, MD and Taehyoung Lee, MD.

CMS Open Payments shows 90 general payments to Dr. Fainberg from 5 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 53% of the total. AngioDynamics, Inc. paid the most, $31,905.

Dr. Fainberg graduated from Tufts University School Of Medicine in 2015.

Dr. Fainberg is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.